巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    AcelRx Pharmaceuticals

    ACRX
    0.253
    0.030
    15.16%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・AcelRx Pharmaceuticals - 延遲價格・最後更新於 29/06 12:14
    最高位
    0.278
    最低位
    0.218
    開市價
    --
    前收市價
    0.220
    成交量(千)
    167.77
    成交額(百萬)
    0.37
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    37.22
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.550 - 0.160
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    AcelRx Pharmaceuticals
    證券代碼
    ACRX.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.
    發行量
    146949320
    公司總部
    25821 Industrial Boulevard, Suite 400
    公司網址
    https://www.acelrx.com
    公司電郵
    investors@acelrx.com
    公司電話
    +1 650 216-3500
    暫無內容

    關於

    AcelRx Pharmaceuticals(ACRX.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.
    詳細公司背景可參考: https://www.acelrx.com